Gains of Chromosome 1p and 15q are Associated with Poor Survival After Cytoreductive Surgery and HIPEC for Treating Colorectal Peritoneal Metastases.
Malin EnbladWilhelm GrafAlexei TermanPascal PucholtBjörn ViklundAnders IsakssonHelgi BirgissonPublished in: Annals of surgical oncology (2019)
This study shows that gains of parts of chromosome 1p and of major parts of chromosome 15q were significantly associated with poor survival after CRS and HIPEC, which could represent future prognostic biomarkers.